NASDAQ:ICCM IceCure Medical - ICCM Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding IceCure Medical Ltd Please log in to your account or sign up in order to add this asset to your watchlist. $1.10 +0.01 (+0.91%) (As of 03/23/2023 12:00 AM ET) Add Compare Share Share Today's Range$1.09▼$1.1350-Day Range$1.05▼$1.4952-Week Range$0.75▼$4.73Volume60,623 shsAverage Volume279,456 shsMarket Capitalization$50.41 millionP/E RatioN/ADividend YieldN/APrice Target$4.38 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media IceCure Medical MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside295.9% Upside$4.38 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews Sentiment-0.09Based on 6 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.44) to ($0.33) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.67 out of 5 starsMedical Sector851st out of 986 stocksSurgical & Medical Instruments Industry86th out of 100 stocks 3.5 Analyst's Opinion Consensus RatingIceCure Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $4.38, IceCure Medical has a forecasted upside of 295.9% from its current price of $1.11.Amount of Analyst CoverageIceCure Medical has only been the subject of 1 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for ICCM. Previous Next 0.0 Dividend Strength Dividend YieldIceCure Medical does not currently pay a dividend.Dividend GrowthIceCure Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ICCM. Previous Next 1.6 News and Social Media Coverage News SentimentIceCure Medical has a news sentiment score of -0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.35 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for IceCure Medical this week, compared to 1 article on an average week.Search Interest10 people have searched for ICCM on MarketBeat in the last 30 days. This is an increase of 11% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, IceCure Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.44% of the stock of IceCure Medical is held by insiders. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for IceCure Medical are expected to grow in the coming year, from ($0.44) to ($0.33) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of IceCure Medical is -2.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of IceCure Medical is -2.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here About IceCure Medical (NASDAQ:ICCM) StockIceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.Read More Receive ICCM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IceCure Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address ICCM Stock News HeadlinesMarch 22, 2023 | americanbankingnews.comHC Wainwright Initiates Coverage on IceCure Medical (NASDAQ:ICCM)March 20, 2023 | finance.yahoo.comIceCure Medical to Report 2022 Full Year Financial & Operational Results on March 29, 2023March 23, 2023 | Weiss Ratings (Ad)Fed's Shocking New Plan to Control Your MoneyThe Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. March 17, 2023 | finance.yahoo.com7 Speculative Penny Stocks to Bet On This MarchFebruary 9, 2023 | finance.yahoo.comIceCure Medical Announces Preliminary Unaudited 2022 Year-End Financial Results & Recent Operational HighlightsJanuary 26, 2023 | finance.yahoo.comIceCure's ProSense Featured in Breast Session at the Society of Interventional Oncology's Annual Scientific Meeting in Washington, D.C.January 25, 2023 | finance.yahoo.comIceCure's ProSense Presented in Hands-On Training Course at The American Society of Breast Surgeons Breast Follows Ultrasound CourseJanuary 24, 2023 | seekingalpha.comICCM IceCure Medical LtdMarch 23, 2023 | Weiss Ratings (Ad)Fed's Shocking New Plan to Control Your MoneyThe Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. January 23, 2023 | finance.yahoo.comU.S. Patent Office Grants Notice of Allowance to IceCure for Novel Cryogenic Pump for Next-Generation Cryoablation SystemsJanuary 18, 2023 | finance.yahoo.comIceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogenic Pump for its Next-Generation Cryoablation SystemsDecember 23, 2022 | finance.yahoo.comIceCure Medical Ltd. Announces Closing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq RulesDecember 21, 2022 | finance.yahoo.comIceCure Medical Ltd. Announces Pricing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq RulesDecember 20, 2022 | finance.yahoo.comIceCure Medical Ltd. Announces Proposed Public OfferingDecember 20, 2022 | proactiveinvestors.comIceCure Medical rockets higher on positive study data showing effectiveness of ProSense kidney tumor treatmentDecember 20, 2022 | benzinga.comWhy Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving PremarketDecember 19, 2022 | nasdaq.com1,000% Move in a Day: Medical Stock Soars on Positive DataDecember 19, 2022 | finance.yahoo.comIceCure's ProSense Safe and Effective in Treating Kidney Tumors with 89.5% Recurrence-Free Rate Based on Interim Study ResultsDecember 19, 2022 | benzinga.comIceCure Medical Stock Is On Fire After Hours: What's Going On?December 8, 2022 | finance.yahoo.comIceCure Medical Ltd (NASDAQ:ICCM) Q3 2022 Earnings Call TranscriptDecember 6, 2022 | finance.yahoo.comIceCure Appoints Vincent Chun Hung Chan to Serve as an Independent Director on its Board of DirectorsDecember 5, 2022 | seekingalpha.comIceCure Medical Ltd (ICCM) Q3 2022 Earnings Call TranscriptDecember 5, 2022 | finance.yahoo.comIceCure Medical Reports Financial Results for the Nine Months Ended September 30, 2022 and Provides Update on Recent Operational HighlightsNovember 30, 2022 | finance.yahoo.comIceCure's ProSense Featured in Poster Presentation at Radiological Society of North America's 2022 Annual MeetingNovember 29, 2022 | finance.yahoo.comTIME CHANGE: IceCure Medical to Report Financial Results for the 9-Month Period Ended September 30, 2022 and Conduct Conference Call on December 5, 2022November 28, 2022 | finance.yahoo.comIceCure Medical to Report Financial Results for the 9-Month Period Ended September 30, 2022 and Conduct Conference Call on December 5, 2022November 8, 2022 | investorplace.comWhat Is Going on With IceCure Medical (ICCM) Stock Today?See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive ICCM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IceCure Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address ICCM Company Calendar Today3/23/2023Next Earnings (Confirmed)3/29/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:ICCM CUSIPN/A CIK1584371 Webwww.icecure-medical.com Phone972-4623-0333Fax972-4623-0222Employees40Year FoundedN/APrice Target and Rating Average Stock Price Forecast$4.38 High Stock Price Forecast$5.75 Low Stock Price Forecast$3.00 Forecasted Upside/Downside+294.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.45) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,900,000.00 Net Margins-462.46% Pretax MarginN/A Return on Equity-77.00% Return on Assets-61.72% Debt Debt-to-Equity Ratio0.03 Current Ratio4.22 Quick Ratio3.58 Sales & Book Value Annual Sales$4.14 million Price / Sales12.23 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares45,620,000Free Float44,510,000Market Cap$50.64 million OptionableNot Optionable Beta-0.25 Key ExecutivesMr. Eyal Shamir (Age 62)CEO & Director Comp: $426kMr. Ronen Tsimerman CPA (Age 54)CFO & COO Comp: $324kMs. Tlalit Bussi Tel-Tzure (Age 52)VP of Bus. Devel. & Global Marketing Comp: $249kMs. Merav Nir Dotan (Age 54)VP of HR Comp: $32kMr. Naum Muchnik (Age 47)VP of Research, Devel. & Engineering Comp: $238kMr. Shay Levav (Age 46)VP of Regulatory and Quality Assurance & Clinical Applications Comp: $239kMore ExecutivesKey CompetitorsCo-DiagnosticsNASDAQ:CODXenVVeno MedicalNASDAQ:NVNODelcath SystemsNASDAQ:DCTHGBSNYSE:GBSIsorayNYSE:ISRView All CompetitorsInstitutional OwnershipBoothbay Fund Management LLCBought 20,000 shares on 2/15/2023Ownership: 0.088%Bank of America Corp DEBought 20,159 shares on 2/10/2023Ownership: 0.121%UBS Group AGBought 26,919 shares on 2/8/2023Ownership: 0.064%View All Institutional Transactions ICCM Stock - Frequently Asked Questions Should I buy or sell IceCure Medical stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for IceCure Medical in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ICCM shares. View ICCM analyst ratings or view top-rated stocks. What is IceCure Medical's stock price forecast for 2023? 3 equities research analysts have issued twelve-month price targets for IceCure Medical's stock. Their ICCM share price forecasts range from $3.00 to $5.75. On average, they predict the company's share price to reach $4.38 in the next twelve months. This suggests a possible upside of 294.1% from the stock's current price. View analysts price targets for ICCM or view top-rated stocks among Wall Street analysts. How have ICCM shares performed in 2023? IceCure Medical's stock was trading at $1.55 at the start of the year. Since then, ICCM stock has decreased by 28.4% and is now trading at $1.11. View the best growth stocks for 2023 here. When is IceCure Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 29th 2023. View our ICCM earnings forecast. How can I listen to IceCure Medical's earnings call? IceCure Medical will be holding an earnings conference call on Wednesday, March 29th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link. What guidance has IceCure Medical issued on next quarter's earnings? IceCure Medical updated its FY 2022 earnings guidance on Thursday, February, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $3.10 million-$3.10 million, compared to the consensus revenue estimate of $3.59 million. What is IceCure Medical's stock symbol? IceCure Medical trades on the NASDAQ under the ticker symbol "ICCM." Who are IceCure Medical's major shareholders? IceCure Medical's stock is owned by a variety of retail and institutional investors. Top institutional investors include Bank of America Corp DE (0.12%), Boothbay Fund Management LLC (0.09%) and UBS Group AG (0.06%). How do I buy shares of IceCure Medical? Shares of ICCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is IceCure Medical's stock price today? One share of ICCM stock can currently be purchased for approximately $1.11. How much money does IceCure Medical make? IceCure Medical (NASDAQ:ICCM) has a market capitalization of $50.64 million and generates $4.14 million in revenue each year. The company earns $-9,900,000.00 in net income (profit) each year or ($0.45) on an earnings per share basis. How can I contact IceCure Medical? The official website for the company is www.icecure-medical.com. The company can be reached via phone at 972-4623-0333, via email at jeremy@lifesciadvisors.com, or via fax at 972-4623-0222. This page (NASDAQ:ICCM) was last updated on 3/23/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.